MedTrace Logo

Syndecan-1 a Surrogate Marker for IBD

NCT01430039 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2015-04-08

No results posted yet for this study

Summary

Syndecan-1 is a protein on the surface intestinal cells. previous studies proved low levels of mucosal syndecan-1 levels on the surface of intestinal cells is patients with acute and chronic inflammation due to inflammatory bowel disease.

this protein might shed from cell surface to the serum. The investigators wish to prove that elevated serum levels of syndecan-1 may be predictive of disease presence, extent and severity, that buy taking a simple blood sample from patients diagnosed with inflammatory bowel disease and comparing to normal subjects and to other markers.

Conditions

  • Inflammatory Bowel Diseases

Interventions

PROCEDURE

blood sample

Blood sample from a peripheral vein, 10ml total for blood count, total serum : protein, albumin, LDH, C-reactive protein,syndecan-1

PROCEDURE

Blood sample - venous blood 10 ml.

venous blood sample from a peripheral vein, 10ml total for blood count, total serum : protein, albumin, LDH, C-reactive protein,syndecan-1

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Assaf Stein, Md · resident

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01430039 on ClinicalTrials.gov